New pyrrolidinium derivatives having the chemical structure of general formula (I)
are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as antagonists of M3 muscarinic receptors.
New pyrrolidinium derivatives having the chemical structure of general formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as antagonists of M3 muscarinic receptors.
PYRROLIDINIUM DERIVATIVES AS ANTAGONISTS OF M3 MUSCARINIC RECEPTORS
申请人:Almirall Prodesfarma AG
公开号:EP1497284A2
公开(公告)日:2005-01-19
US7192978B2
申请人:——
公开号:US7192978B2
公开(公告)日:2007-03-20
[EN] NEW PYRROLIDINIUM DERIVATIVES<br/>[FR] NOUVEAUX DERIVES DU PYRROLIDINIUM
申请人:ALMIRALL PRODESFARMA SA
公开号:WO2003087094A2
公开(公告)日:2003-10-23
New pyrrolidinium derivatives having the chemical structure of general formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as antagonists of M3 muscarinic receptors.